52.00
-0.03 (-0.06%)
-0.03 (-0.06%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.03 | -0.06% | 52.00 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 52.05 | 50.46 | 54.2081 | 51.06 | 52.03 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 48.51 | 60.10 | 11.59 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,056 | 981,905 | $ 51.55 | $ 50,617,938 | 1,379,229 | 18.70 - 54.2081 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:49:21 | formt | 128 | $ 52.00 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 7.63B | 146.69M | 136.82M | $ - | $ - | -1.59 | -26.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 14.20% |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 49.42 | 54.2081 | 48.50 | 50.82 | 1,278,406 | 2.58 | 5.22% |
| 1 Month | 47.32 | 54.2081 | 43.525 | 48.63 | 1,255,711 | 4.68 | 9.89% |
| 3 Months | 37.16 | 54.2081 | 34.007 | 43.95 | 1,183,374 | 14.84 | 39.94% |
| 6 Months | 29.79 | 54.2081 | 24.671 | 36.62 | 1,262,683 | 22.21 | 74.56% |
| 1 Year | 24.31 | 54.2081 | 18.70 | 33.04 | 1,622,062 | 27.69 | 113.9% |
| 3 Years | 9.05 | 54.2081 | 7.26 | 22.68 | 1,407,023 | 42.95 | 474.59% |
| 5 Years | 5.43 | 54.2081 | 4.24 | 20.51 | 985,283 | 46.57 | 857.64% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
